Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance

被引：2

作者：

Tobin, Joshua W. D. ^{[1
,2
]}

Hapgood, Greg ^{[1
,2
]}

Johnston, Anna ^{[4
]}

Cheah, Chan Y. ^{[5
,6
]}

Lee, Sze T. ^{[7
,8
]}

Trotman, Judith ^{[11
,12
]}

Inam, Shafqat ^{[9
]}

Campbell, Belinda A. ^{[8
,10
]}

Norris, Debbie ^{[3
]}

MacManus, Michael ^{[8
,10
]}

Hertzberg, Mark ^{[12
,13
]}

Hawkes, Eliza ^{[7
,8
]}

机构：

[1] Princess Alexandra Hosp, Brisbane, Qld, Australia

[2] Univ Queensland, Brisbane, Qld, Australia

[3] QML Pathol, Brisbane, Qld, Australia

[4] Royal Hobart Hosp, Hobart, Tas, Australia

[5] Sir Charles Gairdner Hosp, Perth, WA, Australia

[6] Univ Western Australia, Perth, WA, Australia

[7] Austin Hlth, Melbourne, Vic, Australia

[8] Univ Melbourne, Melbourne, Vic, Australia

[9] Alfred Hlth, Melbourne, Vic, Australia

[10] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[11] Concord Repatriat Gen Hosp, Sydney, NSW, Australia

[12] Univ Sydney, Sydney, NSW, Australia

[13] Prince Wales Hosp, Sydney, NSW, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2024年 / 54卷 / 08期

关键词：

follicular lymphoma; diagnosis; staging; radiotherapy; chemotherapy; maintenance; STEM-CELL TRANSPLANTATION; NON-HODGKIN-LYMPHOMA; 1ST-LINE TREATMENT; ADVANCED-STAGE; RANDOMIZED-TRIAL; OPEN-LABEL; AUTOLOGOUS TRANSPLANTATION; RITUXIMAB MAINTENANCE; RESPONSE ASSESSMENT; RADIATION-THERAPY;

D O I：

10.1111/imj.16454

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Follicular lymphoma (FL) is the most common indolent non-Hodgkin lymphoma subtype, accounting for 15-20% of all lymphoma diagnoses. Although typically slow-growing and responsive to frontline therapies, advanced-stage FL remains incurable with current treatments and typically follows a chronic relapsing/remitting course with increasingly shorter responses to subsequent lines of therapy. Outcomes are highly variable; some patients experience prolonged first remissions that may approximate a 'functional cure'. By contrast, a significant minority of patients experience disease progression shortly after frontline treatment resulting in high rates of lymphoma-related mortality. Reflecting on the heterogeneous natural history of FL, clinical practice varies widely, particularly in controversial areas, including appropriate disease staging, selection of management strategies and duration of clinical follow-up. This position statement presents an evidence-based synthesis of the literature for application in Australasian practice.

引用

页码：1384 / 1395

页数：12

共 99 条

[11] Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome [J].

Bitansky, Guy ;

Avigdor, Abraham ;

Vasilev, Elena ;

Zlotnick, Maya ;

Ribakovsky, Elena ;

Benjamini, Ohad ;

Nagler, Arnon ;

Kedmi, Meirav .

LEUKEMIA & LYMPHOMA, 2020, 61 (11) :2645-2651

[12] Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG [J].

Brady, Jessica L. ;

Binkley, Michael S. ;

Hajj, Carla ;

Chelius, Monica ;

Chau, Karen ;

Balogh, Alex ;

Levis, Mario ;

Filippi, Andrea Riccardo ;

Jones, Michael ;

Mac Manus, Michael ;

Wirth, Andrew ;

Oguchi, Masahiko ;

Vistisen, Anders Krog ;

Andraos, Therese Youssef ;

Ng, Andrea K. ;

Aleman, Berthe M. P. ;

Choi, Seo Hee ;

Kirova, Youlia ;

Hardy, Sara ;

Reinartz, Gabriele ;

Eich, Hans T. ;

Bratman, Scott V. ;

Constine, Louis S. ;

Suh, Chang-Ok ;

Dabaja, Bouthaina ;

El-Galaly, Tarec C. ;

Hodgson, David C. ;

Ricardi, Umberto ;

Yahalom, Joachim ;

Hoppe, Richard T. ;

Mikhaeel, George .

BLOOD, 2019, 133 (03) :237-245

[13] Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe D'Etude des Lymphomes Folliculaires [J].

Brice, P ;

Bastion, Y ;

Lepage, E ;

Brousse, N ;

Haioun, C ;

Moreau, P ;

Straetmans, N ;

Tilly, H ;

Tabah, I ;

SolalCeligny, P .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :1110-1117

[14] Mosunetuzumab Monotherapy Is an Effective and Well-Tolerated Treatment Option for Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Who Have Received ≥2 Prior Lines of Therapy: Pivotal Results from a Phase I/II Study [J].

Budde, L. Elizabeth ;

Sehn, Laurie H. ;

Matasar, Matthew J. ;

Schuster, Stephen J. ;

Assouline, Sarit ;

Giri, Pratyush ;

Kuruvilla, John ;

Canales, Miguel ;

Dietrich, Sascha ;

Fay, Keith ;

Ku, Matthew ;

Nastoupil, Loretta ;

Wei, Michael C. ;

Yin, Shen ;

Doral, Michelle Y. ;

Li, Chi-Chung ;

Huang, Huang ;

Negricea, Raluca ;

Penuel, Elicia ;

O'Hear, Carol ;

Bartlett, Nancy L. .

BLOOD, 2021, 138

[15] Long-Term Outcomes for Patients With Limited Stage Follicular Lymphoma Involved Regional Radiotherapy Versus Involved Node Radiotherapy [J].

Campbell, Belinda A. ;

Voss, Nick ;

Woods, Ryan ;

Gascoyne, Randy D. ;

Morris, James ;

Pickles, Tom ;

Connors, Joseph M. ;

Savage, Kerry J. .

CANCER, 2010, 116 (16) :3797-3806

[16] The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee [J].

Campo, Elias ;

Jaffe, Elaine S. ;

Cook, James R. ;

Quintanilla-Martinez, Leticia ;

Swerdlow, Steven H. ;

Anderson, Kenneth C. ;

Brousset, Pierre ;

Cerroni, Lorenzo ;

de Leval, Laurence ;

Dirnhofer, Stefan ;

Dogan, Ahmet ;

Feldman, Andrew L. ;

Fend, Falko ;

Friedberg, Jonathan W. ;

Gaulard, Philippe ;

Ghia, Paolo ;

Horwitz, Steven M. ;

King, Rebecca L. ;

Salles, Gilles ;

San-Miguel, Jesus ;

Seymour, John F. ;

Treon, Steven P. ;

Vose, Julie M. ;

Zucca, Emanuele ;

Advani, Ranjana ;

Ansell, Stephen ;

Au, Wing-Yan ;

Barrionuevo, Carlos ;

Bergsagel, Leif ;

Chan, Wing C. ;

Cohen, Jeffrey I. ;

d'Amore, Francesco ;

Davies, Andrew ;

Falini, Brunangelo ;

Ghobrial, Irene M. ;

Goodlad, John R. ;

Gribben, John G. ;

Hsi, Eric D. ;

Kahl, Brad S. ;

Kim, Won-Seog ;

Kumar, Shaji ;

LaCasce, Ann S. ;

Laurent, Camille ;

Lenz, Georg ;

Leonard, John P. ;

Link, Michael P. ;

Lopez-Guillermo, Armando ;

Mateos, Maria Victoria ;

Macintyre, Elizabeth ;

Melnick, Ari M. .

BLOOD, 2022, 140 (11) :1229-1253

[17] Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials [J].

Casulo, Carla ;

Dixon, Jesse G. ;

Le-Rademacher, Jennifer ;

Hoster, Eva ;

Hochster, Howard S. ;

Hiddemann, Wolfgang ;

Marcus, Robert ;

Kimby, Eva ;

Herold, Michael ;

Sebban, Catherine ;

Gyan, Emmanuel ;

Foon, Kenneth ;

Nielsen, Tina ;

Vitolo, Umberto ;

Salles, Gilles A. ;

Shi, Qian ;

Flowers, Christopher R. .

BLOOD, 2022, 139 (11) :1684-1693

[18] Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials [J].

Casulo, Carla ;

Dixon, Jesse G. ;

Ou, Fang-Shu ;

Hoster, Eva ;

Peterson, Bruce A. ;

Hochster, Howard S. ;

Brice, Pauline ;

Ladetto, Marco ;

Hiddemann, Wolfgang ;

Marcus, Robert ;

Kimby, Eva ;

Herold, Michael ;

Nielsen, Tina ;

Morschhauser, Franck ;

Rummel, Mathias ;

Hagenbeek, Anton ;

Vitolo, Umberto ;

Salles, Gilles A. ;

Shi, Qian ;

Flowers, Christopher R. .

BLOOD ADVANCES, 2021, 5 (06) :1737-1745

[19] Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis [J].

Casulo, Carla ;

Friedberg, Jonathan W. ;

Ahn, Kwang W. ;

Flowers, Christopher ;

DiGilio, Alyssa ;

Smith, Sonali M. ;

Ahmed, Sairah ;

Inwards, David ;

Aljurf, Mahmoud ;

Chen, Andy, I ;

Choe, Hannah ;

Cohen, Jonathon ;

Copelan, Edward ;

Farooq, Umar ;

Fenske, Timothy S. ;

Freytes, Cesar ;

Gaballa, Sameh ;

Ganguly, Siddhartha ;

Jethava, Yogesh ;

Kamble, Rammurti T. ;

Kenkre, Vaishalee P. ;

Lazarus, Hillard ;

Lazaryan, Aleksandr ;

Olsson, Richard F. ;

Rezvani, Andrew R. ;

Rizzieri, David ;

Seo, Sachiko ;

Shah, Gunjan L. ;

Shah, Nina ;

Solh, Melham ;

Sureda, Anna ;

William, Basem ;

Cumpston, Aaron ;

Zelenetz, Andrew D. ;

Link, Brian K. ;

Hamadani, Mehdi .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) :1163-1171

[20] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study [J].

Casulo, Carla ;

Byrtek, Michelle ;

Dawson, Keith L. ;

Zhou, Xiaolei ;

Farber, Charles M. ;

Flowers, Christopher R. ;

Hainsworth, John D. ;

Maurer, Matthew J. ;

Cerhan, James R. ;

Link, Brian K. ;

Zelenetz, Andrew D. ;

Friedberg, Jonathan W. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) :2516-U55

← 1 2 3 4 5 6 7 8 9 10 →